Summary of more and less preferred treatments

IF Ivan D. Florez
AV Areti-Angeliki Veroniki
RK Reem Al Khalifah
JY Juan J. Yepes-Nuñez
JS Javier M. Sierra
RV Robin W. M. Vernooij
JA Jorge Acosta-Reyes
CG Claudia M. Granados
GP Giordano Pérez-Gaxiola
CC Carlos Cuello-Garcia
AZ Adriana M. Zea
YZ Yuan Zhang
NF Naghmeh Foroutan
GG Gordon H. Guyatt
LT Lehana Thabane
request Request a Protocol
ask Ask a question
Favorite

For the primary outcome, we developed a system to summarize the results, establishing different groups of interventions (from the best to the worst interventions groups) based on the effect estimates obtained from the NMA, their associated evidence certainty, and their SUCRA (ranking) values. First, we separated moderate-to-high quality (which we define as: high certainty) and low-to-very-low (which we defined as: low certainty) bodies of evidence (based on the GRADE). Then, within each group, we separated treatments based on the magnitude of effect estimates (i.e., based on the magnitude of the effect on reduction in diarrhea duration), as follows: 1)Amongst the best interventions: based on the effect estimates these interventions were all better than STND (they had the largest reduction in diarrhea duration), and also superior to interventions that at the same time, were better than STND (i.e., credible interval of estimates between interventions from group 2 excluded the null value); 2)Inferior to the best but better than the worst interventions: based on the effect estimates these interventions were superior to STND (credible interval of estimates between the intervention and STND excluded the null value), but inferior to interventions from group (1); and 3)Amongst the worst interventions: these interventions showed no differences in effect estimates when compared to STND).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A